183 related articles for article (PubMed ID: 7907892)
1. Immunohistochemical study of c-erbB-2 oncoprotein expression in extramammary Paget's disease.
Nishi M; Yoshida H; Setoyama M; Tashiro M
Dermatology; 1994; 188(2):100-2. PubMed ID: 7907892
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease.
Wolber RA; Dupuis BA; Wick MR
Am J Clin Pathol; 1991 Aug; 96(2):243-7. PubMed ID: 1713741
[TBL] [Abstract][Full Text] [Related]
3. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study.
Keatings L; Sinclair J; Wright C; Corbett IP; Watchorn C; Hennessy C; Angus B; Lennard T; Horne CH
Histopathology; 1990 Sep; 17(3):243-7. PubMed ID: 2173676
[TBL] [Abstract][Full Text] [Related]
4. Loss of Wnt-5α is associated with an invasive phenotype of extramammary Paget's disease.
Xie L; Hayashida S; Furue M
J Cutan Pathol; 2011 Jul; 38(7):576-80. PubMed ID: 21352264
[TBL] [Abstract][Full Text] [Related]
5. erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease.
Takata M; Fujimoto A; Aoki H; Hatta N; Ooi A; Takehara K
J Invest Dermatol; 1999 Aug; 113(2):258-62. PubMed ID: 10469313
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease.
Liegl B; Horn LC; Moinfar F
Mod Pathol; 2005 Oct; 18(10):1283-8. PubMed ID: 15920545
[TBL] [Abstract][Full Text] [Related]
7. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.
Meissner K; Rivière A; Haupt G; Löning T
Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961
[TBL] [Abstract][Full Text] [Related]
8. Mammary Paget's disease and extra-mammary Paget's disease: two morphologically similar but biologically different diseases.
Liu W; Iqbal J; Khoury T
J Cutan Pathol; 2010 Nov; 37(11):1145-9. PubMed ID: 19719834
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal growth factor receptor 2 expression in extramammary Paget's disease and mammary Paget's disease.
Jeong SH; Hyeong JH; Park EJ; Kim KJ; Kim KH
Australas J Dermatol; 2022 Feb; 63(1):115-118. PubMed ID: 34964488
[No Abstract] [Full Text] [Related]
10. Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.
Fujimura T; Kambayashi Y; Hidaka T; Hashimoto A; Haga T; Aiba S
Acta Derm Venereol; 2012 Nov; 92(6):625-8. PubMed ID: 22949100
[TBL] [Abstract][Full Text] [Related]
11. A flow cytometric analysis of the DNA content of Paget cells in the epidermis and the tumor of extramammary Paget's disease.
Mori O; Hachisuka H; Maeyama Y; Sasai Y
Acta Histochem; 1995 Jan; 97(1):99-104. PubMed ID: 7771188
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in patients with extramammary Paget's disease.
Hatta N; Morita R; Yamada M; Echigo T; Hirano T; Takehara K; Ichiyanagi K; Yokoyama K
Dermatol Surg; 2004 Oct; 30(10):1329-34. PubMed ID: 15458530
[TBL] [Abstract][Full Text] [Related]
13. Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell.
Tohmatsu Y; Imura J; Sakai T; Takagi K; Minamisaka T; Tanaka S; Noguchi A; Nakajima T; Nagata T; Makino T; Shimizu T; Fujii T
APMIS; 2021 Jan; 129(1):3-8. PubMed ID: 32996218
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Janus kinase 2 protein in extramammary Paget's disease.
Otsuka-Maeda S; Mijiddorj MT; Kajihara I; Sakamoto R; Yamada-Kanazawa S; Kanemaru H; Nishimura Y; Sawamura S; Makino K; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
Jpn J Clin Oncol; 2021 Jul; 51(7):1176-1178. PubMed ID: 33912910
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of sentinel lymph node biopsy for the detection of metastasis in the early stage of extramammary Paget's disease.
Kusatake K; Harada Y; Mizumoto K; Kaneko S; Niihara H; Chinuki Y; Morita E
Eur J Dermatol; 2015 Apr; 25(2):156-61. PubMed ID: 26075323
[TBL] [Abstract][Full Text] [Related]
16. A case of giant extramammary Paget's disease of the genital area with squamous-cell carcinoma.
Tanabe H; Kishigawa T; Sayama S; Tanaka T
Dermatology; 2001; 202(3):249-51. PubMed ID: 11385233
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratin and erbB-2 oncoprotein in Paget's disease of the nipple. An immunohistochemical study.
Haerslev T; Krag Jacobsen G
APMIS; 1992 Nov; 100(11):1041-7. PubMed ID: 1282021
[TBL] [Abstract][Full Text] [Related]
18. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and fluorescence in situ hybridization studies on noninvasive and invasive extramammary Paget's disease.
Hikita T; Ohtsuki Y; Maeda T; Furihata M
Int J Surg Pathol; 2012 Oct; 20(5):441-8. PubMed ID: 23001873
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle analyses of extramammary Paget's disease.
Mori O; Hachisuka H; Maeyama Y; Sasai Y
Kurume Med J; 1993; 40(3):129-32. PubMed ID: 8139211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
